Myaza 100Mg Inj Substitute
by Others
by Others
by Others
by Others
by Others
by AYUR
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
Composition:
AZACITIDINE-100MG
Uses:
Myelodysplastic syndrome, chronic myelomonocytic leukaemia, and acute myeloid leukaemia.
Medicinal Benefits:
Myaza 100Mg Inj belongs to the group of medicines called anti-metabolites used to treat myelodysplastic syndromes, chronic myelomonocytic leukaemia, and acute myeloid leukaemia. Myaza 100Mg Inj contains Azacitidine, a nucleoside metabolic inhibitor which works by preventing cancer cells from growing. It incorporates into the genetic material of the cells and interferes with the production of new DNA and RNA. This helps correct problems with the maturation and growth of young blood cells in the bone marrow, which causes myelodysplastic disorders.
Myaza 100Mg Inj works by preventing cancer cells from growing. Thereby, it helps treat cancer.
Men should avoid fathering a child whilst on treatment with Myaza 100Mg Inj. Consult the doctor if you wish to conserve your sperm before starting the treatment. Use effective contraception during the treatment with Myaza 100Mg Inj and for three months after stopping the treatment.
Myaza 100Mg Inj may cause a serious immune reaction known as differentiation syndrome. Consult the doctor immediately if you experience fever, rash, difficulty breathing, cough, decreased urine, rapid weight gain, low blood pressure, or swelling of the legs or arms.